Development and evaluation of novel biodegradable transdermal penetration enhancers
新型可生物降解透皮渗透促进剂的开发与评价
基本信息
- 批准号:09672281
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This studies were aimed to develop the transdermal therapeutic system of highly ionizable drugs by ion pair formation with novel biodegradable counter ions.The following results were obtained.(1) Novel biodegradable triglycerides having quaternary ammonium group (YKS) were synthesized as counter ions for ion pair complexation with salicylate or cromoglicate (SCG) (model anionic drugs).The permeability of these anionic drugs through the rat skin was significantly increased by lipophilic ion pair formation in the presence of the YKS.(2) The biodegradability of YKS were illustrated by the pH-stability experiments.Judging from the primary irritation indices, YKS-21 had less cutaneous irritancy compared with Azone.(3) The combination of pretreatment with YKS and ion pair formation was more effective for ion pair transport.(4) The maximum flux and permeability coefficient of SCG from SCG-YKS ion pair in propylene glycol/isopropyl alcohol/isopropyl myristate(15 : 75 : 1O)were about 15 and 3 times respectively higher than those of SCG alone in the same vehicle mixture.(5) The plasma concentrations after topical application to the rat were simulated using obtained permeation and disposition parameters.Although there were some differences in the time course patterns, it was found that the percutaneous penetration of SCG was increased by ion pair formation with YKS in vivo as well.The results of this study suggest that it may be possible through the selection of appropriate counter ions to improve the efficiency of transdermal penetration of other highly ionized drugs, and that ion pair formation is an important consideration in the formulation of ionized drugs.
这项研究的目的是通过离子对形成与新型可生物降解的反离子的高度离子药物的透皮治疗系统。(1)获得了具有Quaternary ammhymonium群(YKS)的新型可生物降解甘油三酸酯(YKS)的新型可生物降解的甘油三酸酯,作为与药物(cromogoglate or cromoglate or scgion compection consection composition comportiation contion consection comportiation composition composition composition)。在YK的存在下,通过亲脂离子对的形成,这些阴离子通过大鼠皮肤的渗透性显着增加。(2)通过pH稳定性实验判断YK的生物降解性。与主要的刺激性指标相比,与Azone相比,YKS-21的皮肤降低了。 (4)在丙烯乙二醇/异丙醇/异丙基醇/异丙基肉豆蔻酸酯(15:75:1O)中,SCG离子对的最大通量和渗透率系数(15:75:1O)的最大通量和渗透率分别比单独使用的静态浓度及其在同一载体中的SCG分别高15倍和3倍。 were some differences in the time course patterns, it was found that the percutaneous penetration of SCG was increased by ion pair formation with YKS in vivo as well.The results of this study suggest that it may be possible through the selection of appropriate counter ions to improve the efficiency of transdermal penetration of other highly ionized drugs, and that ion pair formation is an important consideration in the formulation of ionized drugs.
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kadono M et al.: "Enhanced in Vitro Percutaneous Penetration of Salicytlate by Ion Pair Formation with Alkylamines." Biol.Pharm.Bull.21. 599-603 (1998)
Kadono M 等人:“通过与烷基胺形成离子对增强水杨酸盐的体外经皮渗透。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masanori Kadono: "Enhanced いn Vitro Percutaneous Penetration of Salicylate by lon Pair Formation with Alkylamines" Biol.Pharm.Bull.21巻6号. 599-603 (1998)
Masanori Kadono:“通过与烷基胺形成离子对增强水杨酸盐的体外经皮渗透”Biol.Pharm.Bull.Vol. 21,No. 6. 599-603 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
久保一義: "イオン対形成による皮膚透過性制御と皮膚ターゲッテングの可能性" Fragrance Jounal. 26巻9号. 71-78 (1998)
Kazuyoshi Kubo:“通过离子对形成控制皮肤渗透性和皮肤靶向的可能性”《香水杂志》第 26 卷,第 9. 71-78 期(1998 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kubo K.et al.: "Possibility of Dynamic Control of Skin Permeability by Ion Pair Formation in Topical Drug Targeting" Fragrance Journal. 26. 71-78 (1998)
Kubo K.等人:“局部药物靶向中离子对形成动态控制皮肤渗透性的可能性”《香水杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masanori Kadono: "Enhanced in Vitro Percutaneous Penetration of Salicylate by Ion Pair Formation with Alkylamines" Biol.Pharm.Bull.21巻6号. 599-603 (1998)
Masanori Kadono:“通过与烷基胺形成离子对增强水杨酸盐的体外经皮渗透”Biol.Pharm.Bull.Vol. 21,No. 6. 599-603 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUBO Kazuyoshi其他文献
KUBO Kazuyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUBO Kazuyoshi', 18)}}的其他基金
A study and challenging realization of engineering education applicable to ABET in the field of electronic control engineering
电控工程领域适用于ABET的工程教育的研究与挑战实现
- 批准号:
24653284 - 财政年份:2012
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The invention of the intellectualization cytokine using a synthetic biological response modifier.
使用合成生物反应调节剂的智能化细胞因子的发明。
- 批准号:
11672259 - 财政年份:1999
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The novel synthesis of controlled release polymer with targeting function and application to DDS.
具有靶向功能的控释聚合物的新合成及其在DDS中的应用。
- 批准号:
11557193 - 财政年份:1999
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
Development of functional genomic technologies in mice
小鼠功能基因组技术的发展
- 批准号:
10506700 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication
开发环肽 Nef 抑制剂以促进 HIV-1 根除
- 批准号:
10759561 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Characterize replication competent myeloid reservoirs in the central nervous system
表征中枢神经系统中具有复制能力的骨髓库
- 批准号:
10432131 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Characterize replication competent myeloid reservoirs in the central nervous system
表征中枢神经系统中具有复制能力的骨髓库
- 批准号:
10327112 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Efficacy and PK/PD of a C/EBP beta antagonist in orthotopic breast cancer
C/EBP β 拮抗剂在原位乳腺癌中的疗效和 PK/PD
- 批准号:
10681209 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别: